Mark P McGovern1,2, Chantal Lambert-Harris1, Haiyi Xie2, Andrea Meier1, Bethany McLeman3, Elizabeth Saunders3. 1. Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. 2. Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. 3. Dartmouth Psychiatric Research Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Abstract
BACKGROUND AND AIMS: Post-traumatic stress disorder (PTSD) is common among people with substance use disorders, and the comorbidity is associated with negative outcomes. We report on a randomized controlled trial comparing the effect of integrated cognitive-behavioral therapy (ICBT) plus standard care, individual addiction counseling plus standard care and standard care alone on substance use and PTSD symptoms. DESIGN: Three-group, multi-site randomized controlled trial. SETTING: Seven addiction treatment programs in Vermont and New Hampshire, USA. PARTICIPANTS/CASES: Recruitment took place between December 2010 and January 2013. In this single-blind study, 221 participants were randomized to one of three conditions: ICBT plus standard care (SC) (n = 73), individual addiction counseling (IAC) plus SC (n = 75) or SC only (n = 73). One hundred and seventy-two patients were assessed at 6-month follow-up (58 ICBT; 61 IAC; 53 SC). Intervention and comparators: ICBT is a manual-guided therapy focused on PTSD and substance use symptom reduction with three main components: patient education, mindful relaxation and flexible thinking. IAC is a manual-guided therapy focused exclusively on substance use and recovery with modules organized in a stage-based approach: treatment initiation, early abstinence, maintaining abstinence and recovery. SC are intensive out-patient program services that include 9-12 hours of face-to-face contact per week over 2-4 days of group and individual therapies plus medication management. MEASUREMENTS: Primary outcomes were PTSD severity and substance use severity at 6 months. Secondary outcomes were therapy retention. FINDINGS: PTSD symptoms reduced in all conditions with no difference between them. In analyses of covariance, ICBT produced more favorable outcomes on toxicology than IAC or SC [comparison with IAC, parameter estimate: 1.10; confidence interval (CI) = 0.17-2.04; comparison with SC, parameter estimate: 1.13; CI = 0.18-2.08] and had a greater reduction in reported drug use than SC (parameter estimate: -9.92; CI = -18.14 to -1.70). ICBT patients had better therapy continuation versus IAC (P<0.001). There were no unexpected or study-related adverse events. CONCLUSIONS: Integrated cognitive behavioral therapy may improve drug-related outcomes in post-traumatic stress disorder sufferers with substance use disorder more than drug-focused counseling, but probably not by reducing post-traumatic stress disorder symptoms to a greater extent.
BACKGROUND AND AIMS: Post-traumatic stress disorder (PTSD) is common among people with substance use disorders, and the comorbidity is associated with negative outcomes. We report on a randomized controlled trial comparing the effect of integrated cognitive-behavioral therapy (ICBT) plus standard care, individual addiction counseling plus standard care and standard care alone on substance use and PTSD symptoms. DESIGN: Three-group, multi-site randomized controlled trial. SETTING: Seven addiction treatment programs in Vermont and New Hampshire, USA. PARTICIPANTS/CASES: Recruitment took place between December 2010 and January 2013. In this single-blind study, 221 participants were randomized to one of three conditions: ICBT plus standard care (SC) (n = 73), individual addiction counseling (IAC) plus SC (n = 75) or SC only (n = 73). One hundred and seventy-two patients were assessed at 6-month follow-up (58 ICBT; 61 IAC; 53 SC). Intervention and comparators: ICBT is a manual-guided therapy focused on PTSD and substance use symptom reduction with three main components: patient education, mindful relaxation and flexible thinking. IAC is a manual-guided therapy focused exclusively on substance use and recovery with modules organized in a stage-based approach: treatment initiation, early abstinence, maintaining abstinence and recovery. SC are intensive out-patient program services that include 9-12 hours of face-to-face contact per week over 2-4 days of group and individual therapies plus medication management. MEASUREMENTS: Primary outcomes were PTSD severity and substance use severity at 6 months. Secondary outcomes were therapy retention. FINDINGS: PTSD symptoms reduced in all conditions with no difference between them. In analyses of covariance, ICBT produced more favorable outcomes on toxicology than IAC or SC [comparison with IAC, parameter estimate: 1.10; confidence interval (CI) = 0.17-2.04; comparison with SC, parameter estimate: 1.13; CI = 0.18-2.08] and had a greater reduction in reported drug use than SC (parameter estimate: -9.92; CI = -18.14 to -1.70). ICBT patients had better therapy continuation versus IAC (P<0.001). There were no unexpected or study-related adverse events. CONCLUSIONS: Integrated cognitive behavioral therapy may improve drug-related outcomes in post-traumatic stress disorder sufferers with substance use disorder more than drug-focused counseling, but probably not by reducing post-traumatic stress disorder symptoms to a greater extent.
Authors: John S Cacciola; Arthur I Alterman; A Thomas McLellan; Yi-Ting Lin; Kevin G Lynch Journal: Drug Alcohol Depend Date: 2006-10-11 Impact factor: 4.492
Authors: John S Cacciola; Arthur I Alterman; Kevin G Lynch; Joel M Martin; Megan L Beauchamp; A Thomas McLellan Journal: Drug Alcohol Depend Date: 2007-07-17 Impact factor: 4.492
Authors: Derek D Szafranski; Alexandra Snead; Nicholas P Allan; Daniel F Gros; Therese Killeen; Julianne Flanagan; Irene Pericot-Valverde; Sudie E Back Journal: Addict Behav Date: 2017-04-04 Impact factor: 3.913
Authors: Andrea Meier; Mark P McGovern; Chantal Lambert-Harris; Bethany McLeman; Anna Franklin; Elizabeth C Saunders; Haiyi Xie Journal: Am J Drug Alcohol Abuse Date: 2015-08-18 Impact factor: 3.829
Authors: Elizabeth C Saunders; Bethany M McLeman; Mark P McGovern; Haiyi Xie; Chantal Lambert-Harris; Andrea Meier Journal: J Subst Use Date: 2015-02-03